Huadong Medicine and SynerK to jointly develop a novel siRNA drug SNK-2726
SynerK owns intellectual property rights of SNK-2726, which is currently in the IND filing preparation stage
SynerK owns intellectual property rights of SNK-2726, which is currently in the IND filing preparation stage
Puri is an accomplished leader and financial sector veteran with over four decades of experience
Thyrocare becomes first national diagnostic chain with 100% of its labs with NABL accreditation
The technical program will run in four sessions and a panel discussion on “Challenges in translation of medical technologies”
The segment has immense growth potential driven by the country's increasing healthcare needs, technological innovations, government support, and emerging market opportunities
The report also revealed that 87% of physicians agreed that FEE recommendations would help to improve the speed of recovery
First and only PARP inhibitor to improve overall survival in early breast cancer
The product will be marketed by Dr. Reddy's
Performed within GENEWIZ from Azenta Life Sciences' CLIA-certified and CAP-accredited state-of-the-art clinical genomics laboratory
Subscribe To Our Newsletter & Stay Updated